Home » Topics » BioWorld Science

BioWorld Science
RSS

Akeso Therapeutics presents type III NKT cell compositions

March 16, 2021

NLRP3 inflammasome inhibitors patented by Inflazome

March 16, 2021

Galapagos describes new ENPP2 inhibitors

March 16, 2021

Polycomb protein EED inhibitors identified at Shanghai Blueray Biopharma

March 16, 2021

Shanghai Zhimeng Biopharma discovers Toll-like receptor 8 agonists

March 16, 2021

Phase I studies of hAd5 T-cell COVID-19 vaccine candidate meet safety requirements

March 16, 2021

AstraZeneca provides update on the safety of its COVID-19 vaccine

March 16, 2021

DSMB recommends phase IIb GALACTIC-1 study of GB-0139 to continue with modifications

March 16, 2021

DC-402234 enters phase I clinical development in the U.S.

March 16, 2021

FDA removes clinical hold for phase I/II study of HST-003

March 16, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...